See the DrugPatentWatch profile for Uceris
Uceris is a brand name for a prescription medication containing the active ingredient budesonide [1]. It is used to treat ulcerative colitis [1]. Uceris is available as an extended-release tablet and an extended-release rectal foam [1].
What does Uceris look like?
Uceris tablets are typically round and white or off-white [1]. They are imprinted with the strength of the dosage. The rectal foam is dispensed from an applicator and is white to off-white in color [1].
How does Uceris work?
Uceris is a corticosteroid that works by reducing inflammation in the colon [1]. It is designed to release budesonide gradually in the gastrointestinal tract, targeting inflammation where it is needed most [1].
When can I expect Uceris to be available as a generic?
The patent exclusivity for Uceris may be subject to various legal challenges and expirations. Information on patent status and potential generic availability can be tracked through resources like DrugPatentWatch.com [2].
What are the common side effects of Uceris?
Common side effects reported by patients using Uceris include headache, upper abdominal pain, nausea, fever, fatigue, and increased blood pressure [1].
How does Uceris compare to other ulcerative colitis treatments?
Uceris is one of several treatment options for ulcerative colitis, which also include other corticosteroids, aminosalicylates, immunomodulators, and biologic therapies [3]. The choice of treatment depends on the severity of the disease and individual patient factors [3].
What clinical data supports Uceris's effectiveness?
Clinical trials have demonstrated that Uceris can induce remission in patients with active ulcerative colitis [1]. These studies have evaluated efficacy and safety in various patient populations [1].
Where can I find more information about Uceris?
More detailed information, including prescribing information and patient resources, can be found on the official Uceris website and through healthcare providers [1].
Sources:
[1] https://www.uceris.com/
[2] https://drugpatentwatch.com/
[3] https://www.crohnscolitisfoundation.org/